Search

everythinglearnresearchcommunity

for

Search:↓

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.

Finasteride reduces movement issues in Parkinson's disease rats.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New method makes important drug ingredients more easily without needing extra purification steps.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Compound 4 is a promising treatment for hair loss with low toxicity.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Older adults using diuretics should manage water intake carefully to avoid low sodium levels.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.